Friday turned out to be a nightmare for DURECT Corporation (NASDAQ:DRRX) investors, after the drug maker announced that its pain relief candidate Posimir failed …
Notably, AAPL has reduced projections even during some of the greatest iPhone cycles, says Brian White.
Anthony Chukumba says Price had bad history, and Amazon could use a fresh revamp in Hollywood’s eyes.
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are rising nearly 4% in pre-market trading Friday, after the drug maker announced plans to expand its voclosoprin renal …
Cowen always deemed CELG’s failed drug a risky contender, welcomes GILD’s full approval for Yescarta.
Omeros Corporation (NASDAQ:OMER) announced the presentation of a case report of a patient having co-existing hematopoietic stem cell transplant-associated thrombotic microangiopathy (HCT-TMA) and …
Louise Chen anticipates more generic pricing pressure hit 3Q earnings for generic manufacturers.
Youssef Squali believes strong monetization and user growth have treated FB well during the quarter.
Uniqure NV is back in the race for a hemophilia B gene therapy.
Did this $4 billion fund make the right call on these two soaring biotechs?
